Diligence memo · auto-generated · as of July 2, 2026
Westwood Life Sciences, Llc
Westwood Life Sciences, Llc looks over-valued against its niche peers and is dormant on financing cadence.
Businessfiled
Westwood Life Sciences, Llc operates in Pharmaceuticals, based in CHICAGO.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Westwood Life Sciences, Llc has raised $3.1M in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Seed (a $1.0M–$4.0M round).
Largest single filing: $3.1M on 2016-01-27.
Most recent recorded round closed around 2016-01-27.
Valuation (modeled)modeled
Provath models Westwood Life Sciences, Llc at approximately $116M (range $2.3M–$913M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Over-valued. Modeled value is 1.93× the median modeled value of Seed Pharmaceuticals companies in 2016–2018 (71 peers) — value vs value, same stage and era. Issuer reports no revenue, yet is modeled well above niche peers.
Financing rhythm & timingmixed
Last raise 10.4 yr ago; this sector typically re-raises about every 13 months.
Only one round on record and long silent — often defunct, acquired, or gone quiet.
Comparablesmixed
Capital scale ranks ahead of 35% of Pharmaceuticals peers (1613 compared).
Modeled value ranks above 57% of those peers.
Closest niche peers: Chase Therapeutics Corp, Acura Pharmaceuticals, Inc, Paragon Biosciences Skyline Capital, LLC, Phoenix PharmaLabs Inc, Saghmos Therapeutics, Inc..
Peoplefiled
1 named person on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
Modeled above niche peers — valuation risk on entry.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.